Opioid and benzodiazepine prescribing after COVID‐19 hospitalization

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization is not well understood. We aimed to characterize opioid and benzodiazepine prescribing among naïve patients hospitalized for COVID and to identify the risk factors associated with a new prescription at discharge. In this retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaney, Lia D., Bicket, Mark C., Hu, Hsou Mei, O'Malley, Megan, McLaughlin, Elizabeth, Flanders, Scott A., Vaughn, Valerie M., Waljee, Jennifer F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347718/
https://www.ncbi.nlm.nih.gov/pubmed/35621024
http://dx.doi.org/10.1002/jhm.12842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347718/
https://www.ncbi.nlm.nih.gov/pubmed/35621024
http://dx.doi.org/10.1002/jhm.12842

Ejemplares similares